Informed-money record

VNDA · Vanda Pharmaceuticals Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$0 / $5.6M

Recent disclosures

14 of 14 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-19	5%+ holder (13G) MILLENNIUM MANAGEMENT LLC	disclosed a passive stake (13G)	—	SEC ↗
2026-05-18	Director Mitchell Stephen Ray	gifted	—	SEC ↗
2026-03-02	SVP, CFO & Treasurer (via Merrill Lynch) Kevin Moran	filed notice to sell	$351K	SEC ↗
2026-03-02	Officer (via Merrill Lynch) Mihael H. Polymeropoulos	filed notice to sell	$1.3M	SEC ↗
2026-03-02	SVP, Chief Marketing Officer (via Merrill Lynch) Joakim Wijkstrom	filed notice to sell	$255K	SEC ↗

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals